Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Have been diagnosed with plaque psoriasis for at least 6 months.~* Have plaque psoriasis covering at least 15% of their total body.~* Be a candidate for phototherapy or systemic treatment of psoriasis (either naïve or history of previous treatment).~* Be willing and able to comply with scheduled visits, treatment plan and other study procedures.~Exclusion Criteria:~* Currently have non-plaque forms of psoriasis or drug-induced psoriasis.~* Subject cannot discontinue systemic therapies and/or topical therapies for the treatment of psoriasis and cannot discontinue phototherapy.~* Subject is participating in another trial using an investigational agent or procedure.~* Women who are pregnant or breast-feeding or considering becoming pregnant.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: EXPERIMENTAL): None
- 3 (Type: EXPERIMENTAL): None
- 4 (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).